FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009645911> ?p ?o ?g. }

• W2009645911 endingPage "402" @default.
• W2009645911 startingPage "401" @default.
• W2009645911 abstract "Pneumonia remains a common yet vexing complication of critical illness. While it is the most common nosocomial infection in ICUs, and the one most commonly associated with death, its diagnosis remains the subject of ongoing investigations, heated debate, and a disquieting amount of “art of medicine.” The article by Wu and colleagues in this issue of CHEST (see page 662) does not, of itself, provide insight into how we may improve outcomes for our patients suspected of having nosocomial pneumonia (and specifically ventilator-associated pneumonia [VAP]). It does, however, add to an increasing body of evidence that suggests that, when cultured quantitatively, invasive and noninvasively obtained cultures should provide comparable information. Linking this with improved outcomes for our patients is more problematic and involves an assessment of the risks of inappropriate treatment, whether changing antibiotic therapy in response to culture data alters outcome, and the role that antibiotic use patterns play in the selection of drug-resistant pathogens in the ICU. The number of studies1Fagon J-Y Chastre J Hance AJ et al.Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients.Chest. 1993; 103: 547-553Abstract Full Text Full Text PDF PubMed Scopus (306) Google Scholar2Winer-Muram HT Rubin SA Ellis JV et al.Pneumonia and ARDS in patients receiving mechanical ventilation: diagnostic accuracy of chest radiography.Radiology. 1993; 188: 479-485Crossref PubMed Scopus (121) Google Scholar3Chastre J Viau F Brun P et al.Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients.Am Rev Respir Dis. 1984; 130: 924-929PubMed Google Scholar4Andrews CP Coalson JJ Smith JD et al.Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury.Chest. 1981; 80: 254-258Crossref PubMed Scopus (358) Google Scholar indicating that the combination of qualitative cultures and clinical data has a high false-positive rate in diagnosing VAP is large and generally consistent. However, the lack of a “gold standard” or criterion standard for establishing a diagnosis of VAP is problematic. This is especially true in light of reports5Wermert D Marquette CH Copin MC et al.Influence of pulmonary bacteriology and histology on the yield of diagnostic procedures in ventilator-acquired pneumonia.Am J Respir Crit Care Med. 1998; 158: 139-147Crossref PubMed Scopus (72) Google Scholar6Kirtland SH Corley DE Winterbauer RH et al.The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria.Chest. 1997; 112: 445-457Abstract Full Text Full Text PDF PubMed Scopus (226) Google Scholar7Marquette CH Copin MC Wallet F et al.Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard.Am J Respir Crit Care Med. 1995; 151: 1878-1888Crossref PubMed Scopus (301) Google Scholar suggesting that reliance solely on invasively obtained and quantitatively cultured samples using rigid diagnostic cut points may result in underdiagnosis of VAP. Studies examining the impact on relevant clinical outcomes of using quantitative cultures to obtain a more accurate diagnosis have been contradictory, or at least difficult to interpret. Fagon et al,8Fagon J-Y Chastre J Wolff M et al.Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial.Ann Intern Med. 2000; 132: 621-630Crossref PubMed Scopus (738) Google Scholar in a multicenter prospective randomized trial in > 400 patients, found that the use of antibiotics and early mortality was lower in patients in whom the diagnosis of pneumonia was made using quantitative cultures of bronchoscopically obtained specimens, in contrast to patients in whom qualitative cultures of tracheal aspirates were used. While this study has been criticized for not demonstrating a reduction in mortality rate at 28 days, there was a significant reduction in 28-day mortality using a proportionate hazards multivariate analysis. Several studies9Dupont H Mentec H Sollet JP et al.Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia.Intensive Care Med. 2001; 27: 355-362Crossref PubMed Scopus (262) Google Scholar10Kollef MH Sherman G Ward S et al.Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.Chest. 1999; 115: 462-474Abstract Full Text Full Text PDF PubMed Scopus (1578) Google Scholar11Rello J Gallego M Mariscal D et al.The value of routine microbial investigation in ventilator-associated pneumonia.Am J Respir Crit Care Med. 1997; 156: 196-200Crossref PubMed Scopus (444) Google Scholar have found that inappropriate antibiotic therapy of VAP is associated with increased mortality rates. While this has not been a consistent finding, even in studies where there was no significant difference, the trend toward increased mortality with inadequate therapy is compelling and suggests the possibility of a type II statistical error.12Heyland DK Cook DJ Griffith L et al.The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient.Am J Respir Crit Care Med. 1999; 159: 1249-1256Crossref PubMed Scopus (680) Google Scholar Interestingly, it appears that it is the initial, empiric, antibiotic therapy that has the greatest impact on outcome.9Dupont H Mentec H Sollet JP et al.Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia.Intensive Care Med. 2001; 27: 355-362Crossref PubMed Scopus (262) Google Scholar13Luna CM Vujacich P Niederman MS et al.Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.Chest. 1997; 111: 676-685Abstract Full Text Full Text PDF PubMed Scopus (826) Google Scholar Given this, why be concerned about specimens whose results will be unavailable for 48 to 72 h, long after empiric therapy has been started? There are two reasons. First, the use of quantitative cultures in an institution should permit a more accurate determination of the organisms responsible for VAP in that institution and thereby improve the accuracy of the initial antibiotic prescription. Second, the data of Fagon et al8Fagon J-Y Chastre J Wolff M et al.Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial.Ann Intern Med. 2000; 132: 621-630Crossref PubMed Scopus (738) Google Scholar strongly suggest that if quantitative culture findings are negative, antibiotics can be safely discontinued. This has important implications for the ICU. Antibiotic use patterns play an important role in the emergence of antibiotic-resistant organisms. This appears to be based on both the frequency and duration of antibiotic administration.14Guillemot D Carbon C Balkau B et al.Low dosage and long treatment duration of lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.JAMA. 1998; 279: 365-370Crossref PubMed Scopus (537) Google Scholar15Seppala H Klaukka T Vuopio-Varkila J et al.The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland: Finnish Study Group for Antimicrobial Resistance.N Engl J Med. 1997; 337: 441-446Crossref PubMed Scopus (1078) Google Scholar Stopping empiric antibiotic therapy for VAP when quantitative culture findings are negative may facilitate decreased antibiotic use with attendant reductions in both cost and in the antibiotic-forced selection of resistant organisms. Were bronchoscopy routinely employed to collect specimens from patients suspected of VAP, it would place a potentially untenable time and cost burden on health-care systems. Bronchoscopy, however, does not appear to be routinely necessary. Ruiz et al16Ruiz M Torres A Ewig S et al.Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome.Am J Respir Crit Care Med. 2000; 162: 119-125Crossref PubMed Scopus (290) Google Scholar found no difference in mortality or antibiotic use when comparing tracheal aspirates (TAs) with bronchoscopically obtained specimens, both of which were cultured quantitatively. However, the study was small, enrolling only 76 patients, and was probably underpowered to detect clinically relevant differences in outcomes. Similarly, Bregeon et al,17Bregeon F Papazian L Visconti A et al.Relationship of microbiologic diagnostic criteria to morbidity and mortality in patients with ventilator-associated pneumonia.JAMA. 1997; 277: 655-662Crossref PubMed Google Scholar in a prospective, case-controlled study comparing outcomes in patients in whom a diagnosis of VAP was made using quantitative cultures obtained from invasively obtained vs noninvasively obtained samples, found no difference in outcomes among 76 pairs of patients matched on several clinical variables. The correlation between quantitatively cultured TA specimens and bronchoscopically collected specimens appears to be good. El-Ebiary and colleagues18El-Ebiary M Torres A Gonzalez J et al.Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia.Am Rev Respir Dis. 1993; 148: 1552-1557Crossref PubMed Google Scholar found very good correspondence between these techniques. This has been reconfirmed in the current study by Wu and colleagues in a population that is extraordinarily common in most ICUs: patients already receiving antibiotic therapy. Significantly, quantitative cultures of TA specimens were at least as sensitive and nearly as specific as bronchoscopically obtained specimens. Hence, use of a 105 threshold for TA cultures should minimize the potential for not treating a pneumonia that is present, while maintaining reasonable specificity and permitting the discontinuation of antibiotic therapy in a large number of patients without pneumonia. Further, antibiotic sensitivities of species collected by invasive and noninvasive means were similar, arguing that there will be little difference in antibiotic use patterns or culture-directed changes in antibiotic therapy consequent to the use of one specimen or the other. TAs are not routinely cultured quantitatively in most hospitals in the United States. The reasons for this are several and include increased cost and uncertainty as to how these data should be applied clinically. However, the cost of quantitative cultures should be more than offset by the decrease in antibiotic usage. Fagon et al8Fagon J-Y Chastre J Wolff M et al.Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial.Ann Intern Med. 2000; 132: 621-630Crossref PubMed Scopus (738) Google Scholar found 4 more antibiotic-free days in the group being managed using quantitative culture; and, in the study of Wu and colleagues, nearly half of the quantitative TA cultures were below the threshold indicating pneumonia. While many of these patients may yet receive antibiotic therapy for nonpulmonary indications, it is hard to escape the conclusion that antibiotic administration can be reduced if quantitative cultures (of TAs) are employed and antibiotics discontinued if culture findings are negative. Hence, quantitative cultures can assist the physician in more accurately diagnosing VAP, permit an institution to better ascertain the organisms most commonly responsible for VAP, and permit physicians to more accurately target empiric antibiotic therapy, without increasing cost or adding procedure-related morbidity. It is hard to imagine more compelling arguments for the broad application of quantitative cultures of respiratory secretions in suspected VAP. However, we must now focus our research efforts, not on isolated aspects of the process of care of patients with VAP, but on the comparison of clinically relevant and well-delineated diagnostic and treatment algorithms on the important outcomes of mortality and cost of care." @default.
• W2009645911 created "2016-06-24" @default.
• W2009645911 creator A5000526238 @default.
• W2009645911 date "2002-08-01" @default.
• W2009645911 modified "2023-09-23" @default.
• W2009645911 title "Cultures and Ventilator-Associated Pneumonia" @default.
• W2009645911 cites W1903742027 @default.
• W2009645911 cites W1970637369 @default.
• W2009645911 cites W1983513589 @default.
• W2009645911 cites W1984195945 @default.
• W2009645911 cites W2018536347 @default.
• W2009645911 cites W2085769132 @default.
• W2009645911 cites W2091493523 @default.
• W2009645911 cites W2097596146 @default.
• W2009645911 cites W2113081830 @default.
• W2009645911 cites W2129097224 @default.
• W2009645911 cites W2134804037 @default.
• W2009645911 cites W2139206072 @default.
• W2009645911 cites W2148706534 @default.
• W2009645911 cites W2151310380 @default.
• W2009645911 cites W2162258048 @default.
• W2009645911 cites W2164871906 @default.
• W2009645911 cites W2172039031 @default.
• W2009645911 cites W2321640152 @default.
• W2009645911 doi "https://doi.org/10.1378/chest.122.2.401" @default.
• W2009645911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12171808" @default.
• W2009645911 hasPublicationYear "2002" @default.
• W2009645911 type Work @default.
• W2009645911 sameAs 2009645911 @default.
• W2009645911 citedByCount "4" @default.
• W2009645911 countsByYear W20096459112013 @default.
• W2009645911 crossrefType "journal-article" @default.
• W2009645911 hasAuthorship W2009645911A5000526238 @default.
• W2009645911 hasBestOaLocation W20096459111 @default.
• W2009645911 hasConcept C126322002 @default.
• W2009645911 hasConcept C177713679 @default.
• W2009645911 hasConcept C2777184939 @default.
• W2009645911 hasConcept C2777914695 @default.
• W2009645911 hasConcept C71924100 @default.
• W2009645911 hasConceptScore W2009645911C126322002 @default.
• W2009645911 hasConceptScore W2009645911C177713679 @default.
• W2009645911 hasConceptScore W2009645911C2777184939 @default.
• W2009645911 hasConceptScore W2009645911C2777914695 @default.
• W2009645911 hasConceptScore W2009645911C71924100 @default.
• W2009645911 hasIssue "2" @default.
• W2009645911 hasLocation W20096459111 @default.
• W2009645911 hasLocation W20096459112 @default.
• W2009645911 hasOpenAccess W2009645911 @default.
• W2009645911 hasPrimaryLocation W20096459111 @default.
• W2009645911 hasRelatedWork W1986900569 @default.
• W2009645911 hasRelatedWork W1990710887 @default.
• W2009645911 hasRelatedWork W1991657305 @default.
• W2009645911 hasRelatedWork W2022477326 @default.
• W2009645911 hasRelatedWork W2033280291 @default.
• W2009645911 hasRelatedWork W2054761248 @default.
• W2009645911 hasRelatedWork W2410854040 @default.
• W2009645911 hasRelatedWork W2575220005 @default.
• W2009645911 hasRelatedWork W2590474856 @default.
• W2009645911 hasRelatedWork W3031519838 @default.
• W2009645911 hasVolume "122" @default.
• W2009645911 isParatext "false" @default.
• W2009645911 isRetracted "false" @default.
• W2009645911 magId "2009645911" @default.
• W2009645911 workType "article" @default.